FDA Inspection
Glenmark Pharmaceuticals LimitedGlenmark Pharmaceuticals Limited – FDA Inspection, Mar 31, 2017
Record Details
This FDA Inspection record concerns Glenmark Pharmaceuticals Limited, with an inspection on March 31, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · a5c21800-ad37-4711-9700-04664fe379a5
Inspection Facts
- Inspection number
- 1011069
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Glenmark Pharmaceuticals Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 20, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2019 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| March 15, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 30, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 19, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Glenmark Pharmaceuticals Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.